Back to News
Market Impact: 0.35
QUICK SPARK: J&J Eyes Worst Day Since April 2025 with MedTech Miss
Source: benzinga.com
Corporate EarningsCorporate Guidance & OutlookCompany Fundamentals
Johnson & Johnson beat profit estimates and raised its full-year forecast on Tuesday, but its stock is heading for its worst day in more than 18 months. The article gives no profit figures, forecast details, or share-price decline magnitude.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.05
Ticker Sentiment
JNJ0.35
More News
- Meta shares rise for a second straight day as new AI model family impresses
- J&J's 6% slide on an imperfect quarter is a gift to prospective buyers
- J&J beats earnings estimates; Middle East conflict weighs on medical-device sales
- Wall St edges lower as chips fall; markets assess big bank earnings
- Wall Street Banks Face New Pressure
- Johnson & Johnson shares SLIDE nearly 6% despite stronger full-year forecast